According to the latest research report by IMARC Group, The India over the counter (OTC) drugs market size reached US$ 7.6 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 19.4 Billion by 2028, exhibiting a growth rate (CAGR) of 16.7% during 2023-2028. More Info:- https://www.imarcgroup.com/india-over-the-counter-drugs-market
According to the latest research report by IMARC Group, The global over the counter (OTC) drugs market size reached US$ 158.8 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 231.7 Billion by 2028, exhibiting a growth rate (CAGR) of 6.24% during 2023-2028. More Info:- https://www.imarcgroup.com/over-the-counter-drugs-market
The report covers aspects such as pharmaceutical market segment (by Prescription & OTC Drugs, by Patented & Generic Drugs), competitive landscape of major players in the Singapore pharmaceutical market... For more information on the research report, refer to below link: https://www.kenresearch.com/healthcare/pharmaceuticals/singapore-pharmaceutical-market/149668-91.html
Big Market Research “OTC Drugs Markets in China” Size, Share, Industry Trends, Demand, Insights, Analysis, Research, Report, Opportunities, Company Profiles, Forecast to 2019. Visit for more info @ http://www.bigmarketresearch.com/otc-drugs-in-china-market China’s demand for OTC Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades.
Big Market Research present “OTC Pharmaceuticals Market” Size, Share, Industry Trends, Demand, Insights, Analysis, Research, Report, Opportunities, Company Profiles, Forecast to 2018. Visit for more info @ http://www.bigmarketresearch.com/otc-pharmaceuticals-in-latin-america-2014-2018-market The OTC Pharmaceuticals Market in Latin America market to grow at a CAGR of 14.54 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing switch from prescription to OTC drugs.
A newly published report by Market Statsville Group (MSG), title Global OTC Drugs Market provides an exhaustive analysis of significant industry insights and historical and projected global market figures. MSG expects the global OTC Drugs market will showcase an impressive CAGR from 2024 to 2033. The comprehensive OTC
According to the latest research report by IMARC Group, The United States obesity drugs market size is projected to exhibit a growth rate (CAGR) of 18.3% during 2024-2032. More Info:- https://www.imarcgroup.com/united-states-obesity-drugs-market
According to the latest research report by IMARC Group, The global over the counter (OTC) drugs market size reached US$ 168.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 275.9 Billion by 2032, exhibiting a growth rate (CAGR) of 5.5% during 2024-2032. More Info:- https://www.imarcgroup.com/over-the-counter-drugs-market
The Over-the-counter drug market is flourishing. According to a report by Ken Research, the global OTC Drug market size reached a substantial $137.39 billion in 2024 and is projected to reach a staggering $163.10 billion by 2029, boasting a healthy CAGR (Compound Annual Growth Rate) of 3.49%.
The global OTC drugs market is estimated to garner a revenue of ~ USD 294 billion by the end of 2035 by growing at a CAGR of ~7% over the forecast period, i.e., 2023 – 2035.
The global over the counter drugs & dietary supplements market is driven by growth in awareness related to general health concerns and advancements in healthcare and pharmaceutical industries. In addition, growing trend among individuals to select OTC drugs for minor diseases supplements the market growth.
For more information kindly visit : https://www.bharatbook.com/drugs-market-research-reports-400900/otc-drugs-china1.html Bharat Book Bureau provides the report, on “ OTC Drugs Markets in China”. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants.
According to the latest research report by IMARC Group, The global over the counter (OTC) drugs market size reached US$ 158.8 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 231.7 Billion by 2028, exhibiting a growth rate (CAGR) of 6.24% during 2023-2028. More info:- https://www.imarcgroup.com/over-the-counter-drugs-market
According to the latest research report by IMARC Group, The United States over the counter (OTC) drugs market size reached US$ 25.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 37.6 Billion by 2032, exhibiting a growth rate (CAGR) of 4.45% during 2024-2032. More Info:- https://www.imarcgroup.com/united-states-over-the-counter-drugs-market
Inkwood Research estimates that the Global OTC Artificial Tears Market is set to grow with a CAGR of 5.12% in terms of revenue during the forecasting years of 2021-2028.
The global acne drugs market size reached US$ 6.1 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 9.1 Billion by 2027, exhibiting a growth rate (CAGR) of 7.4% during 2022-2027 More info: https://www.imarcgroup.com/acne-drugs-market
The global antiobesity market is expected to grow from $1.46 billion in 2020 to $2.4 billion in 2021 at a compound annual growth rate (CAGR) of 64.4%. The market is expected to reach $5.42 billion in 2025 at a CAGR of 22.6%.
OTC drugs that are available for the treatment of gastrointestinal diseases are laxatives, anti-flatulents, H2-antaginists, anti-diarrheals, PPIs, and anti-emetics. The OTC drugs are not bound by regulatory guidelines, but need to comply with the drug monograph of a country. Analysts forecast the global gastrointestinal OTC drugs market to grow at a CAGR of 1.48% over the period 2014-2019. Read more details at: http://www.bigmarketresearch.com/global-gastrointestinal-otc-drugs-2015-2019-market
According to the latest research report by IMARC Group, The India over the counter (OTC) drugs market size reached US$ 7.6 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 19.4 Billion by 2028, exhibiting a growth rate (CAGR) of 16.7% during 2023-2028. More Info:- https://www.imarcgroup.com/india-over-the-counter-drugs-market
Ophthalmology Drugs Market presents insights on the current and future industry trends, which helps to drive the revenue growth and profitability - says TBRC. https://bit.ly/2OoT2V1
This report studies the Global Gastrointestinal OTC Drugs market status and forecast, categorizes the global Gastrointestinal OTC Drugs market size (value & volume) by manufacturers, type, application, and region.
Global Over the Counter OTC Drugs & Dietary Supplements market competition by top manufacturers, with production, price, revenue value and market share for each manufacturer; the top players including Pfizer Novartis International Roche Holding Merck Sanofi Johnson & Johnson
The Global Over-the-counter (OTC) drugs market share report provides numbers for applications and regional segments of the industry covering historical as well as forecast data for decision makers.
Global vitamin deficiency treatment market is expected to rise from its initial estimated value by registering a substantial CAGR during the forecast period of 2019-2026. This rise in market value can be attributed to the increased awareness towards health of people globally. The report contains data of the base year 2018 and historic year 2017.
Indonesia Pharmaceutical market has registered an increase in the revenue at a CAGR of ~% from USD ~ billion in 2012 to USD ~ billion in 2017. For more information on the research report, refer to below link: https://www.kenresearch.com/healthcare/pharmaceuticals/indonesia-pharmaceutical-market/143542-91.html
Over the counter (OTC) drugs are those drugs which can be picked by consumer without the prescription of doctors intended to use for diagnosis, cure, mitigation, treatment or prevention of disease. These OTC need to be labelled safe, effective, pure and accurate by the concerned government authority before they could go into the market.
Over-The-Counter (OTC) Drugs Market size is expected to grow rapidly during the forecast period due to rising geriatric population and increasing demand from patients to treat various medical conditions without requiring physician’s consultation. As per WHO estimates, the worldwide elderly population aged 65 years and above is set to rise to 16% by 2050 from 7% in 2000, fueling the demand for medicines in the future.
The Over-the-Counter (OTC) drug market, valued at an impressive $162.2 billion in 2022, steps in. Projected to reach a staggering $245.9 billion by 2032, with a healthy CAGR of 5.3%.
Global pharmaceutical drugs market size is expected at 1,848.49 Bn by 2027 at a growth rate of 11.4% and industry demand by The Business Research Company.
By exploring and comparing these key 4 markets aim to give the reader the best indication of how these markets will progress to 2025; which OTC areas will offer the most growth and what location specific issues any entrant to the respective OTC markets can face.
According to the latest research report by IMARC Group, The global xerostomia (dry mouth disease) therapeutics market size reached US$ 739.8 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 985.0 Million by 2032, exhibiting a growth rate (CAGR) of 3.13% during 2024-2032. More Info:- https://www.imarcgroup.com/xerostomia-therapeutics-market
Global otc drug and dietary supplement market size is expected to reach $438.93 Bn by 2028 at a rate of 7.2%, segmented as by category, vitamin and dietary supplements, cough and cold products, analgesics, gastrointestinal products, sleep aids
According to the latest research report by IMARC Group, The global FMCG packaging market size reached US$ 761.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 1,126.7 Billion by 2032, exhibiting a growth rate (CAGR) of 4.25% during 2024-2032. More Info:- https://www.imarcgroup.com/fmcg-packaging-market
Global botanicals and acupuncture market size is expected to reach $197.08 Bn by 2028 at a rate of 20.9%, segmented as by intervention, botanicals, acupuncture
The global pharmacies and healthcare stores market grew from $1,192.37 billion in 2022 to $1,274.74 billion in 2023 at a compound annual growth rate (CAGR) of 6.9%.
The increasing prevalence of autoimmune diseases among individuals and the rising number of patients suffering from SLE represents one of the major factors driving the demand for SLE drugs around the world Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: Visit the following link: https://www.imarcgroup.com/systemic-lupus-erythematosus-drugs-market E-mail: sales@imarcgroup.com Contact: +91-120-415-5099
According to the latest research report by IMARC Group, The global onychomycosis treatment market size reached US$ 3.1 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 4.3 Billion by 2028, exhibiting a growth rate (CAGR) of 5.37% during 2023-2028. More Info:- https://www.imarcgroup.com/onychomycosis-treatment-market
Looking forward, the acne drugs market value is projected to reach a strong growth during the forecast period (2021-2026). More info:- https://www.imarcgroup.com/acne-drugs-market
Big Market Research present “Global Anti-Obesity Drugs Market” Size, Share, Industry Trends, Demand, Insights, Analysis, Research, Report, Opportunities, Company Profiles, Forecast to 2019. Visit for more info @ http://www.bigmarketresearch.com/global-anti-obesity-drugs-2015-2019-market Obesity is a medical condition in which there is surplus accumulation of fat in the body. It is linked with increased illness risk, disability, and death. Although anti-obesity drugs are available in the market, their effectiveness is restricted to maintain weight rather than cure.
The Business Research Company offers pharmaceutical api manufacturing market research report 2022 with industry size, share, segments and market growth https://bit.ly/3Dx74vN
Antiglaucoma Drugs Industry Research is the latest report by The Business Research Company, which throws light on specific drivers, restraints, opportunities, challenges and other factors that oppose market growth. https://bit.ly/3aRwkjU
North America was the largest region in the dermatology drugs market in 2017, accounting for around 31% market share. The USA was the largest country in the market in 2017, accounting for over 24% market share. Read Report https://www.thebusinessresearchcompany.com/report/dermatology-drugs-global-market-report-2018
Major players in the Anti-obesity Drugs Market are F. Hoffmann-La Roche AG, GlaxoSmithKline PLC, Boehringer Ingelheim GmbH, and Pfizer Inc. Read More @ https://bit.ly/3t1IBZj
The global ophthalmic drugs market is estimated to grow at an approximate CAGR of 7.86% during the period of 2017 and 2024.An existing predominance and increase in the number of eye disorders with growing geriatric population all over the world are the primary drivers responsible for the market growth.